mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
-0.089 |
0.003 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.003 |
mRNA |
VX-680 |
GDSC1000 |
pan-cancer |
AAC |
-0.16 |
0.004 |
mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
-0.15 |
0.004 |
mRNA |
MST-312 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.004 |
mRNA |
betulinic acid |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.004 |
mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
-0.093 |
0.004 |
mRNA |
PI-103 |
GDSC1000 |
pan-cancer |
AAC |
-0.089 |
0.004 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.005 |
mRNA |
CD-437 |
CTRPv2 |
pan-cancer |
AAC |
-0.092 |
0.005 |